Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,349 | -168,385 | -135,956 | -115,909 | 121,190 |
| Depreciation Amortization | -4,528 | -11,405 | -15,030 | -5,205 | 29 |
| Accounts payable and accrued liabilities | 8,487 | 206 | 1,701 | -1,983 | 10,289 |
| Other Working Capital | 16,482 | -7,476 | 16,163 | -46,586 | -247,845 |
| Other Operating Activity | 5,877 | 51,561 | 47,727 | 48,701 | 29,332 |
| Operating Cash Flow | $-132,031 | $-135,499 | $-85,395 | $-120,982 | $-87,005 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 188,793 | 56,105 | 40,303 | -453,467 | N/A |
| PPE Investments | N/A | N/A | N/A | -1,943 | -4 |
| Investing Cash Flow | $188,793 | $56,105 | $40,303 | $-455,410 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 259 | 267 | 257 | 370 | 1,465 |
| Common Stock Repurchased | -25,519 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -485 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-25,745 | $267 | $257 | $370 | $1,465 |
| Beginning Cash Position | 64,696 | 143,823 | 188,658 | 764,680 | 850,224 |
| End Cash Position | 95,713 | 64,696 | 143,823 | 188,658 | 764,680 |
| Net Cash Flow | $31,017 | $-79,127 | $-44,835 | $-576,022 | $-85,544 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,031 | -135,499 | -85,395 | -120,982 | -87,005 |
| Capital Expenditure | N/A | N/A | N/A | -1,943 | -4 |
| Free Cash Flow | -132,031 | -135,499 | -85,395 | -122,925 | -87,009 |